Ordinance on Prevention of Hazards Due to Specified Chemical Substances
Ministry of Labour Ordinance No. 39 of September 30, 1972
Attached Table 3 (related to Article 39)
| Work | Period | Items |
|---|---|---|
| (1) Work to manufacture or handle the substances given below.1) Benzidine and its salts. 2) ?A-naphthylamine and its salts. 3) Dichlorobenzidine and its salts. 4) ??-naphthylamine and its salts. 5) O-tolidine and its salts. 6) Dianisidine and its salts. 7) P-dimethylamino azobenzene. 8) Magenta. 9) Chemicals and other substances containing these substances, listed in item 1) to 8), of more than 1% by weight. |
6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as hematuria, pollakisuria, pain on urination, etc.3. Examination for presence of objective or subjective symptoms such as hematuria, pollakisuria, pain on urination, etc.4. Microscopic examination of urine sediment (cytological examination by the Papanicolaou technique on urine sediment when regarded necessary by medical doctors). |
| (2) Work to manufacture or handle bis (chloromethyl) ether (inclusive of chemicals and other substances which contain bis (chloromethyl) ether of more than 1% by weight). | 6 months | 1. Investigation of working history.2 Review of past history of presence of objective or subjective symptoms such as cough, sputum, chest pain, body weight loss, etc., resulting from bis (chloromethyl) ether.3. Examination for presence of objective or sub-jective symptoms such as cough, sputum, chest pain, body weight loss, etc.4. Examination with direct roentgenography on chest on those who have been engaged in work for more than three years. |
| (3) Work to manufacture or handle chlorinated biphenyl. | 6 months | 1. Investigation of working history.2. Review of past history of presence of dermatological symptoms, hepatic damage, etc., resulting from chlorinated biphenyl.3. Examination for presence of objective or subjective symptoms such as appetite loss, sense of weakness, etc.4. Examination for presence of dermatological findings such as hair follicle acne, darkening of skin, etc.5. Testing for urobilinogen in urine. |
| (4) Work to manufacture or handle beryllium, etc. | 6 months | 1. Investigation of working history.2. Review of past history of presence of respiratory symptoms, allergic symptoms, etc., resulting from beryllium, etc.3. Examination for presence of objective or subjective symptoms such as dry cough, sputum, pharyngodynia, throat irritation, chest pain, chest uneasiness, shortness of breath, palpitation, difficult breathing, malaise, appetite loss, body weight loss, etc.4. Examination for presence of dermatological findings such as dermatitis, etc.5. Measurement of lung vital capacities. |
| 1 year | Direct examination of chest with roentgenography. | |
| (4-2) Work to manufacture or handle benzotrichloride (inclusive of chemicals and other substances which contain benzotrichloride of more than 0.5% by weight). |
6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as cough, sputum, chest pain, nasal discharge, epistaxis, olfactory sensory loss, sinusitis, nasal polyposis.3. Examination for presence of objective or subjective symptoms such as cough, sputum, chest pain, nasal discharge, epistaxis, olfactory sensory, sinusitis, nasal polyposis, lymph node swelling on neck, etc.4. Examination for dermatological findings such as verruca, pigmentation, etc.5. Direct roentgenography examination of chest for those were engaged in work for more than 3 years as described in the provisions of item (9) of Article 23 of the Enforcement Order. |
| (5) Work to manufacture or handle acrylamide (inclusive of chemicals and substances which contain acrylamide of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as paresthesia in extremities, gait disturbances, abnormal sweating, etc.3. Examination for presence of objective or subjective symptoms such as paresthesia in extremities, gait disturbances, abnormal sweating, etc.4. Examination for presence of dermatological findings such as dermatitis. |
| (6) Work to manufacture or handle acrylonitrile (inclusive of chemicals and substances which contain acrylonitrile of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as heaviness in the head, headache, irritation in upper respiratory tract, general malaise, easy fatigue, nausea, vomiting, epistaxis, etc., resulting from acrylonitril.3. Examination for presence of objective or subjective symptoms such as heaviness in the head, head ache, irritation in the upper respiratory tract, general malaise, easy fatigue, chills, vomiting, nasal hemorrhage, etc. |
| (7) Work to manufacture or handle alkyl mercury compounds (inclusive of substances which contain alkyl mercury compounds of more than 1% of their weights. | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as heaviness in the head, headache, abnormal senses of lips or upper and lower extremities, althralgia, insomnia, sleepiness, depression, uneasiness, disturbance in gait, tremor in fingers, body weight loss, etc. resulting from alkyl mercury compounds.3. Examination for presence of objective or subjective symptoms such as abnormal senses in lips or upper and lower extremities, althralgia, insomnia, disturbance in gait, tremor in fingers, body weight loss, etc.4. Examination for presence of dermatological findings such as dermatitis, etc. |
| (8) Work to manufacture or handle asbestos, etc. | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as cough, sputum, shortness of breath, chest pain, etc., resulting from asbestos etc.3. Examination for presence of objective or subjective symptoms such as cough, sputum, shortness of breath, chest pain, etc.4. Direct examination of chest with roentgenography. |
| (9) Work to manufacture or handle ethyleneimine (inclusive of substances which contain ethyleneimine of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as headache, cough, sputum, chest pain, vomiting, mucous irritation symptoms, etc., resulting from ethyleneimine.3. Examination for presence of objective or subjective symptoms such as headache, cough, sputum, chest pain, vomiting, mucous irritation symptoms, etc.4. Examination for presence of dermatological findings such as dermatitis. |
| (10) Work to manufacture or handle vinyl chloride (inclusive of chemicals and substances which contain vinyl chloride of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as general malaise, easy fatigue, appetite loss, uncertain upper abdominal symptoms, jaundice, tarry stools, pallidness, pain or abnormal sense in fingers, etc. resulting from vinyl chloride.3. Examination for presence of objective or subjective symptoms such as headache, dizziness, tinnitus, general malaise, easy fatigue, uncertain upper abdominal symptoms, jaundice, tarry stools, pain or abnormal sense in fingers, etc.4. Examination for presence of hepatomegaly or splenomegaly.5. Hepatic functional examination covering items such as serum bilirubi, serum (GOT), serum (GPT), ALP, etc.6. Direct examination of chest with roentgenography for those engaged in the said work for more than 10 years. |
| (11) Work to manufacture or handle chlorine (inclusive of substances which contain chemicals and the substances which contain chlorine of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as respiratory symptoms, ophthalmologic symptoms, etc. resulting from chlorine.3. Examination for presence of objective or subjective symptoms such as cough, sputum, upper respiratory tract irritation symptoms, tearing, abnormalities of corneas, vision disturbances, dental changes, etc. |
| (12) Work to manufacture or handle auramine (inclusive of substances which contain suramine of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as hematuria pollakysuria, pain on urination, etc.3. Examination for presence of objective or subjective symptoms such as hematuria, pollakysuria, pain on urination, etc.4. Microscopic examination of urine sediment (cytological examination by the Papanicolaou technique on urine sediment when found necessary by medical doctors.5. Testing for urobilinogen in urine. |
| (13) Work to manufacture or handle of O-phthalodinitrile (inclusive of substances which contain O-phthalodinitrile of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as epilepsy-like attack.3. Examination for presence of objective or subjective symptoms such as headache, heaviness in the head, forgetfulness, insomnia, malaise, nausea, poor appetite, facial pallidness, tremor in fingers, etc.4. Testing for urobilinogen in urine. |
| (14) Work to manufacture or handle cadmium or its compounds (inclusive of chemicals and substances which contain cadmium or its compounds of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of symptoms such as respiratory symptoms, gastrointestinal symptoms, etc. resulting from cadmium or its compounds.3. Examination for presence of objective or subjective symptoms such as cough, sputum, irritation in throat, abnormalities in nasal mucous membranes, shortness of breath, poor appetite, nausea, vomiting, repeated abdominal pain or diarrhea, body weight loss, etc.4. Examination for presence of cadmium accumulated in yellow circles on incisor tooth or canine tooth.5. Testing for presence of urinary protein. |
| (15) Work to manufacture or handle chromic acid, etc. | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as cough, sputum, chest pain, abnormalities in nasal cavity, dermatological symptoms, etc., resulting from chromic acid or bichromate.3. Examination for presence of objective or subjective symptoms such as cough, sputum, chest pain, etc.4. Examination for presence (or absence) of nasal cavity findings such as abnormalities in nasal membrane, perforation.5. Examination for presence of dermatological findings such as dermatitis, ulcers, etc.6. Direct examination of chest with roentgenography for those engaged in work, as provided in item (4) of Article 23 in the Enforcement Order, for more than 4 years. |
| (16) Work to manufacture or handle chloromethylmethylether (inclusive of chemicals and substances which contain chloromethylmethylether of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as cough, sputum, chest pain, body weight loss, etc., resulting from chloromethylmethylether.3. Examination for presence of objective or subjective symptoms such as cough, sputum, chest pain, body weight loss, etc.4. Direct examination of chest with roentgenography. |
| (17) Work to manufacture or handle vanadium pentoxide (inclusive of chemicals and substances which contain vanadium pentoxide of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as respiratory symptoms, etc., resulting from vanadium pentoxide.3. Examination for presence of objective or subjective symptoms such as cough, sputum, chest pain, dyspnea, tremor in fingers, dermatological pallidness, green tongue, cornification of the palm of fingertips, etc.4. Measurement of lung capacity.5. Measurement of blood pressure levels. |
| (18) Work to manufacture or handle coal tar (inclusive of chemicals or substances which contain coal tar of more than 5% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as gastrointestinal symptoms, respiratory symptoms, dermatological symptoms, etc. resulting from coal tar.3. Examination for presence of objective or subjective symptoms such as poor appetite, cough, sputum, ophthalmologic pain, etc.4. Examination for presence of dermatological findings such as dermatitis in exposed sites, acne changes, melanosis, vernica, ulcers, gaseous spots, etc.5. Direct examination of chest with roentgenography for those engaged in work, as provided in item (6) of Article 23 in the Enforcement Order, for more than 5 years. |
| (19) Work to manufacture or handle arsenic trioxide (inclusive of chemicals or substances which contain arsenic trioxide of more then 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as abnormalities in nasal membrane, respiratory symptoms, stomatitis, diarrhea, constipation, body weight loss, abnormal senses, etc. resulting from arsenic trioxide.3. Examination for presence of objective or subjective symptoms such as cough, sputum, poor appetite, body weight loss, abnormal senses, etc.4. Examination for presence of nasal cavity findings such as abnormalities in nasal membrane, perforation in nasal cavity, etc.5. Examination for dermatological findings such as dermatitis, pigmentation, depigmentation, cornification, etc. 6. Testing for urinary urobilinogen levels.7. Direct examination of chest with roentgenography for those engaged in work, as provided in item (5) of Article 23 in the Enforcement Order, for more than 5 years. |
| (20) Work to manufacture or handle the substances given below. 1) Potassiumcyanide. 2) Hydrogencyanide. 3) Sodiumcyanide. 4) Chemicals and substances containing more than 5% by weight of the chemicals and substances listed in l) or 3). 5) Chemicals and other substances containing more than 1% by weight of the substance listed in 2). |
6 months | 1. Investigation of working history.2. Investigation of working conditions.3. Review of past history of presence of objective or subjective symptoms such as heaviness in the head, headache, fatigue, malaise, hyperemia of conjunctiva, abnormaltaste, gastrointestinal symptoms, etc.4 Examination for presence of objective or subjective symptoms such as heaviness in the head, headache, fatigue, malaise, hyperemia ofconjunctiva, abnormal taste, gastrointestinal symptoms, etc.5 Testing of urinary urobilinogen levels. |
| (21) Work to manufacture or handle 3,3'-dichloro-4,4'-diaminodiphenylmethane (inclusive of substances which contain 3,3'-dichloro-4,4'- diaminodiphenylmethane of more than 1% by weights.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as abnormalities in upper abdomen, malaise, cough, sputum, chest pain, haematuria, etc., resulting from 3-3'-dichloro-4-4'diaminodiphenylmethane.3. Examination for presence of objective or subjective symptoms such as abnormalities in upper abdomen, malaise, cough, sputum, chest pain, haematuria, etc.4. Hepatic functional examination. |
| (22) Work to manufacture or handle methyl bromide (inclusive of chemicals or substances which contain methyl bromide of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as heaviness in the head, headache, dizziness, tearing, rhinitis, throat pain, cough, poor appetite, nausea, vomiting, abdominal pain, diarrhea, paresthesia in upper and lower extremities, decreased sight, decreased memory, dysarthria, increased reflex in tendon, disturbances in gait, etc., resulting from methyl bromide.3. Examination for presence of objective or subjective symptoms such as heaviness in the head, headache, dizziness, poor appetite, paresthesia in upper and lower extremities, decreased sight, decreased memory, dysarthria, increased reflex in tendon, disturbances in gait, etc.4 Examination for the presence of dermatological findings. |
| (23) Work to manufacture or handle mercury or its inorganic compounds (inclusive of chemicals and substances which contain mercury or its inorganic compounds of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as headache, insomnia, tremor in fingers, oliguria, polyuria, inflammation of gums, stomatitis, etc., resulting from mercury or its inorganic compounds.3. Examination for presence of objective or subjective symptoms such as headache, insomnia, tremor in fingers, oliguria, polyuria, inflammation of gums, stomatitis, etc., resulting from mercury or its inorganic compounds.4. Examination for presence of urinary occult blood and protein. |
| (24) Work to manufacture or handle trilenediisocyanate (inclusive of chemicals and other substances which contain trilenediisocyanate of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as headache, ophthalmologic pain, nasal pain, throat pain, abnormal feeling in throat, cough, sputum, sense of chest compression, shortness of breath, chest pain, dyspnea, general malaise, mucous inflammation in eyes, nose, or throat, body weight loss, allergic asthma, etc., resulting from trilenediisocyanate.3. Examination for presence of objective or subjective symptoms such as heaviness in the head, headache, ophthalmologic pain, nasal pain, throat pain, abnormal feeling in throat, cough, sputum, chest compression sense, shortness of breath, chest pain, dyspnea, general malaise, mucous inflammation in eyes, nose or throat, body weight loss, allergic asthma, etc.4. Examination for presence of dermatological findings such as dermatitis. |
| (25) Work to manufacture or handle nickel carbonyl (inclusive of chemicals and other substances which contain nickel carbonyl of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as headache, dizziness, nausea, vomiting, cough, chest pain, dyspnea, itching, abnormalities in nasal mucous membrane, etc. resulting from nickel carbonyl.3. Examination for presence of objective or subjective symptoms such as headache, dizziness, nausea, vomiting, cough, chest pain, dyspnea, itching, abnormalities in nasal mucous membrane, etc. |
| 1 year | Direct examination of chest with roentgenography. | |
| (26) Work to manufacture or handle nitroglycol (inclusive of chemicals and other substances which contain nitroglycol of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as headache, abnormal feeling in the chest, cardiac symptoms, paresthesia in upper and lower extremities, cooling sensation, neuralgia, malaise, etc. resulting from nitroglycol.3. Examination for presence of objective or subjective symptoms such as heaviness in the head, headache, stiffness in shoulders, abnormal feeling in the chest, cardiac symptoms, paresthesia in upper and lower extremities, cooling sense, neuralgia, malaise, gastrointestinal symptoms, etc.4. Measurement of blood pressure levels.5. Testing of blood in respect to its total specific gravity, and erythrocytic systems covering blood count of red blood cells, etc. |
| (27) Work to manufacture or handle P-nitrochlorobenzene (inclusive of chemicals or substances which contain P-nitrochlorobenzene of more than 5% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as heaviness in the head, headache, dizziness, malaise, fatigue, facial pallidness, cyanosis, anemia, palpitations, coloured urine, etc.3. Examination for presence of objective or subjective symptoms such as heaviness in the head, headache, dizziness, malaise, fatigue, facial pallidness, cyanosis, anemia, palpitation, coloured urine, etc.4. Testing for urinary urobilinogen. |
| (28) Work to manufacture or handle hydrogen fluoride (inclusive of chemicals or substances which contain hydrogen fluoride of more than 5% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as respiratory symptoms, ophthalmologic symptoms, etc., resulting from hydrogen fluoride.3. Examination for presence of objective or subjective symptoms such as mucous inflammation of the eyes, noseor mouth, change in tooth colour, etc.4. Examination for presence of dermatological findings such as dermatitis.5. Testing for urinary urobilinogen. |
| (29) Work to manufacture or handle β -propiolactone (inclusive of chemicals and substances which contain β-propiolactone of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as cough, sputum, chest pain, body weight loss, etc. resulting from β-propiolactone.3. Examination for presence of objective or subjective symptoms such as cough, sputum, chest pain, body weight loss, etc.4. Examination for dermatological findings such as dermatitis in exposed sites.5. Direct examination of chest with roentgenography. |
| (30) Work to manufacture or handle benzene, etc. | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as heaviness in the head, headache, dizziness, palpitation, malaise, paresthesia in upper and lower extremities, poor appetite, bleeding tendency, etc. resulting from benzene.3. Examination for presence of objective or subjective symptoms such as heaviness in the head, headache, dizziness, palpitation, malaise, paresthesia in upper and lower extremities, poor appetite, etc.4. Testing of blood in respect to the total specific gravity, and erythrocytic systems covering blood count of red blood cells, etc.5. Testing for blood count of white blood cells. |
| (31) Work to manufacture or handle pentachlorophenol (otherwise called PCP) or its sodium salts (inclusive of chemicals and substances which contain pentachlorophenol and its sodium salts of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as cough, sputum, throat pain, irritation in throat, headache, dizziness, easy fatigability, malaise, gastrointestinal symptoms such as poor appetite, preference for sweet materials, excessive sweating, fever, palpitation, ophthalmologic pain, itching, etc., resulting from pentachlorophenol or its sodium salts.3. Examination for presence of objective or subjective symptoms such as cough, sputum, throat pain, irritation in throat, headache, dizziness, easy fatigability, malaise, gastrointestinal symptoms such as poor appetite, preference for sweets, excessive sweating, ophthalmologic pain, itching, etc.4. Examination for presence of dermatological findings such as dermatitis, etc.5. Measurement of blood pressure levels.6. Testing of urinary sugar and urobilinogen. |
| (32) Work to manufacture or handle manganese or its compounds (inclusive of manganese or its compounds) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as cough, sputum, mask-like faces, salve faces, ptyalismus, abnormal sweating, tremors in the fingers, unskillful lettering, disturbances in gait, disturbances of involuntary motion, dysarthria, etc., as in Parkinson's syndrome.3. Examination for presence of cough, sputum, mask-like face, salve faces, ptyalismus abnormal sweating, tremor in fingers, unskillful lettering, disturbances in gait, disturbances of involuntary motion, dysarthria as symptoms as in Parkinson's syndrome.4. Measurement of grasping power. |
| (33) Work to manufacture or handle methyl iodide (inclusive of chemicals and other substances which contain methyl iodide of more than 1%) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as heaviness in the head, dizziness, sleepiness, nausea, vomiting, malaise, dimness of sight, etc., resulting from methyl iodide.3. Examination for presence of objective or subjective symptoms such as heaviness in the head, dizziness, sleepiness, nausea vomiting, malaise, dimness of sight, etc.4. Examination for presence of dermatological findings such as dermatitis. |
| (34) Work to manufacture or handle hydrogen sulfide (inclusive of chemicals and other substances which contain hydrogen sulfide of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as respiratory symptoms, ophthalmologic symptoms, etc., resulting from hydrogen sulfide.3. Examination for presence of objective or subjective symptoms such as headache, sleeplessness, easy fatigability, dizziness, easy excitability, nausea, cough, upper respiratory tract irritation, gastrointestinal symptoms, abnormalities in conjunctiva and cornea, changed teeth. |
| (35) Work to manufacture or handle dimethyl sulfide (inclusive of chemicals and other substances which contain dimethyl sulfide of more than 1% by weight.) | 6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as respiratory symptoms, ophthalmologic symptoms, dermatological symptoms, etc., resulting from dimethyl sulfide.3. Examination for presence of objective or subjective symptoms such as cough, sputum, hoarseness, tearing, abnormalities in conjunctivaand cornea, senses of powerlessness, gastrointestinal symptoms, etc.4. Examination for presence of dermatological findings such as dermatitis, etc.5. Testing of urinary urobilinogen or protein. |
| (36) Work to manufacture or handle the substances given below, for use in experimentation and research. 1) 4-aminodiphenyl and its salts. 2) 4-nitrodiphenyl and its salts. 3) Chemicals and other substances which contain substances listed in items 1) and 2) more than 1% by weight. . |
6 months | 1. Investigation of working history.2. Review of past history of presence of objective or subjective symptoms such as hematuria, pollakysuria, pain on urination, etc.3. Examination for presence of objective or subjective symptoms such as hematuria, pollakysuria, pain on urination, etc.4. Microscopic examination of urine sediment (cytological examination by the Papanicolaou technique on urine sediment when found necessary by medical doctors.) |
このページの先頭へ